Avoiding methodological bias in studies of amyloid imaging results disclosure
Alzheimers Res Ther
.
2019 Jun 4;11(1):52.
doi: 10.1186/s13195-019-0495-y.
Authors
Carl Taswell
1
2
,
Cheryl Donohue
3
,
Maree T Mastwyk
3
,
Andrea G Louey
3
,
Jacqueline Giummarra
3
,
Joanne Robertson
3
,
David G Darby
3
,
Colin L Masters
3
,
Christopher C Rowe
3
4
Affiliations
1
Brain Health Alliance, Ladera Ranch, CA, USA. ctaswell@BrainHealthAlliance.org.
2
Department Psychiatry, University California San Diego, La Jolla, CA, USA. ctaswell@BrainHealthAlliance.org.
3
Florey Institute Neuroscience and Mental Health, University Melbourne, Parkville, VIC, Australia.
4
Austin Health Department Molecular Imaging, Melbourne, VIC, Australia.
PMID:
31159862
PMCID:
PMC6547470
DOI:
10.1186/s13195-019-0495-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease*
Amyloid
Amyloidogenic Proteins
Disclosure
Humans
Substances
Amyloid
Amyloidogenic Proteins